New protein test can detect 18 early stage cancers, scientists say
The team from U.S. biotech firm Novelna wrote: “At stage I (the earliest cancer stage) and at the specificity of 99%, our panels were able to identify 93% of cancers among males and 84% of cancers among females.” It believes its cheaper, less invasive multi-cancer screening test could be a ‘gamechanger.’